Why this exists
The bottleneck is local permission.
In high-cost clinical domains, the pain starts after the evidence is already strong enough for serious review but before action feels institutionally safe.
- Committee caution compounds long after the science moves.
- Delay shows up in real events, utilization, and margin.
- The organization holding the margin is the one paying for the lag.
- Analytics alone do not move protocol behavior.